-
Featured
Improving the Safety of Vena Caval Thrombectomy in Kidney Cancer with Tumor Thrombus Team Approach
Complete removal of a tumor thrombus resulting from venous tumor invasion is essential for eliminating the cancer in patients with advanced renal cell carcinoma (RCC). A multispecialty tumor thrombus team within an integrated practice can improve the safety of this intricate and extensive procedure.
-
Featured
Dusting Vs. Basketing: Strategies for Disintegrating Renal Stones
Dusting, a new protocol for treating kidney stones using recent laser technologies, has proven to deliver successful patient outcomes equal to those of traditional basketing, according to a study by the Endourology Disease Group for Excellence.
-
Featured
Benefits of Cytoreductive Nephrectomy with Targeted Cancer Therapy for Metastatic Renal Cell Cancer
Since the advent of targeted cancer therapies in the mid-2000s, there has been a dramatic reduction in cytoreductive nephrectomies. Dr. Michael Blute of Massachusetts General Hospital states that the reduction is concerning, since cytoreductive nephrectomy can provide a strong survival advantage to patients with metastatic disease.
-
Pathways Case Record: A Patient With Renal Failure Found to Have Nephrotic Syndrome With Histopathological Findings of Podocyte Effacement
A 63-year-old man with renal failure underwent a kidney biopsy for presumed nephrotic syndrome, which revealed severe podocyte injury. The Pathways Service was consulted to elucidate the current mechanism of injury to the patient's podocytes and the pathophysiologic underpinnings of his nephrotic syndrome.
-
Multi-Biomarker Panel Predicts CV Events in Patients With Chronic Kidney Disease
For assessing patients with chronic kidney disease, James L. Januzzi, MD, Reza Mohebi, MD, and colleagues have developed a panel of four biomarkers that have different roles in the pathophysiology of cardiovascular disease and may be useful as a unique tool for predicting cardiovascular events.
-
Mortality Related to Surgical Staplers and Clip Appliers Is Increasing
Matthew F. Wszolek, MD, and colleagues present evidence from an FDA database suggesting the use of surgical staplers and clip appliers, especially in urologic, gastrointestinal, hepatic and spleen procedures, may be more dangerous to patients than previously appreciated.
Kidney Contributors
-
Brian Howard Eisner, MD
Co-Director, Kidney Stone Program, Assistant Professor of Surgery, Harvard Medical School
Recent Article
Diabetes Not a Risk Factor for Septic Shock Among Patients With Ureteral Stone and UTI -
-
Michael G. Fitzsimons, MD
Interim Director, Division of Cardiac Anesthesia, CABG Redesign Committee, CABG Redesign Pre-op Subcommittee chair
Recent Article
Improving the Safety of Vena Caval Thrombectomy in Kidney Cancer with Tumor Thrombus Team Approach -
Michael L. Blute, MD
Chief, Department of Urology, Walter S. Kerr, Jr., Professor of Surgery, Harvard Medical School
Recent Article
Orthotopic Neobladder Reconstruction Restores Quality of Life for Female Cystectomy Patients -
Mukesh G. Harisinghani, MD
Director, Abdominal MRI, Department of Radiology, Massachusetts General Hospital
Recent Article
Review: Advances in Radiologic Staging of Colorectal Cancer